Previous 10 | Next 10 |
ENGLEWOOD, Colo. , July 28, 2020 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics...
In this episode of Industry Focus: Wildcard , Jason Moser chats with Motley Fool analyst Brian Feroldi about three promising healthcare stocks that he personally bought. Discover their innovative products, which facilitate easy and quick diagnosis of peripheral artery disease -- plus, a "medi...
ENGLEWOOD, Colo., July 23, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagn...
Last week was a repeat of the uptrend we have been seeing in the market, with the S&P 500 up more than 1.2%, and the Nasdaq up 2.2%. Over the last three months, the S&P 500 is up over 12%, and the Nasdaq, more than 21%. Considering we had barely exited the first phase of COVID-19 befor...
Shares of Zynex (NASDAQ: ZYXI) , a medical device manufacturer, are down by 9.9% as of 11:23 a.m. EDT on Wednesday, after the company announced the pricing of a public offering of common stock after the market closed on Tuesday. Zynex's decision to sell additional shares isn't sitting well wi...
Perceptron (NASDAQ: PRCP ) -15% . More news on: Perceptron, Inc., Zynex, Inc., Rigel Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Zynex (NASDAQ: ZYXI ) has priced its public offering of 2.5M common shares (1.25M company's shares and 1.25M by selling shareholders) at $22.00/share, for expected gross proceeds of ~$27.5M. The company will not receive any proceeds from the offering. More news on: Zynex, Inc., He...
ENGLEWOOD, Colo. , July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagn...
ENGLEWOOD, Colo. , July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostic...
Shares of Zynex (NASDAQ: ZYXI) , a medical devices manufacturer, are up by 12.1% as of 12:22 p.m. EDT on Friday, after the company announced on Thursday that it had experienced an increase in orders during the second quarter. As a result, Zynex revised its second-quarter and full-year revenue...
News, Short Squeeze, Breakout and More Instantly...
Zynex Reports Second Quarter 2024 Financial Results PR Newswire Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the ma...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...